Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Extension Study in Tourette's Disorder
NCT01727713Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jan 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of aripiprazole in Tourette syndrome (TS), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Jan 2013; status: completed.
02
Drugs
aripiprazole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT01727713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01727713.